Sign in

CIK 0001761918

  • Emerging growth company

Erasca, Inc.

Sign in to watch
Ticker
ERAS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
831217027
Phone
+1 858-465-6511
Business address
3115 MERRYFIELD ROW, THIRD FLOOR, SAN DIEGO, CA, 92121
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-01-29 Chacko David M. CFO and CBO Grant or award · Stock option (right to buy) +640,000 640,000
2025-12-15 Chacko David M. CFO and CBO Other acquisition +17,793 $1.19 $21K 279,980
2025-02-03 Chacko David M. CFO and CBO Grant or award · Stock option (right to buy) +800,000 800,000
2024-12-13 Chacko David M. CFO and CBO Other acquisition +12,324 $1.56 $19K 262,187
2024-06-20 Chacko David M. CFO and CBO Grant or award · Stock Option (right to buy) +278,812 278,812
2024-06-14 Chacko David M. CFO and CBO Other acquisition +3,137 $1.56 $5K 262,187
2024-02-05 Chacko David M. CFO and CBO Grant or award · Stock Option (right to buy) +600,000 600,000
2023-12-15 Chacko David M. CFO and CBO Other acquisition +7,478 $1.59 $12K 246,726
2023-02-01 Chacko David M. Chief Financial Officer Other acquisition +1,748 $4.10 $7K 239,248
2023-02-01 Chacko David M. Chief Financial Officer Other acquisition +2 $3.89 $8 239,248
2023-02-01 Chacko David M. Chief Financial Officer Grant or award · Stock Option (right to buy) +600,000 600,000
2022-02-01 Chacko David M. Chief Financial Officer Other acquisition +1,562 $11.60 $18K 237,498
2022-02-01 Chacko David M. Chief Financial Officer Grant or award · Stock Option (Right to Buy) +366,125 366,125

Page 1 of 1 · 13 trades